BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 19001871)

  • 1. Identification of beta-catenin as a novel substrate of Polo-like kinase 1.
    Arai T; Haze K; Iimura-Morita Y; Machida T; Iida M; Tanaka K; Komatani H
    Cell Cycle; 2008 Nov; 7(22):3556-63. PubMed ID: 19001871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cotargeting Polo-Like Kinase 1 and the Wnt/β-Catenin Signaling Pathway in Castration-Resistant Prostate Cancer.
    Li J; Karki A; Hodges KB; Ahmad N; Zoubeidi A; Strebhardt K; Ratliff TL; Konieczny SF; Liu X
    Mol Cell Biol; 2015 Dec; 35(24):4185-98. PubMed ID: 26438599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1.
    Mbom BC; Siemers KA; Ostrowski MA; Nelson WJ; Barth AI
    Mol Biol Cell; 2014 Apr; 25(7):977-91. PubMed ID: 24501426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFBD1/MDC1 is phosphorylated by PLK1 and controls G2/M transition through the regulation of a TOPOIIα-mediated decatenation checkpoint.
    Ando K; Ozaki T; Hirota T; Nakagawara A
    PLoS One; 2013; 8(12):e82744. PubMed ID: 24349352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional independency between catalytic activity and subcellular targeting of polo-like kinase-1: phenotypes of ectopic overexpression of various mutants.
    Ji JH; Jang YJ
    Cell Cycle; 2008 Jun; 7(11):1597-603. PubMed ID: 18560274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of rictor as a novel substrate of Polo-like kinase 1.
    Shao T; Liu X
    Cell Cycle; 2015; 14(5):755-60. PubMed ID: 25714006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B23/nucleophosmin serine 4 phosphorylation mediates mitotic functions of polo-like kinase 1.
    Zhang H; Shi X; Paddon H; Hampong M; Dai W; Pelech S
    J Biol Chem; 2004 Aug; 279(34):35726-34. PubMed ID: 15190079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P21-activated kinase is required for mitotic progression and regulates Plk1.
    Maroto B; Ye MB; von Lohneysen K; Schnelzer A; Knaus UG
    Oncogene; 2008 Aug; 27(36):4900-8. PubMed ID: 18427546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential Plk1 targets in a cell-cycle specific proteome through structural dynamics of kinase and Polo box-mediated interactions.
    Bibi N; Parveen Z; Rashid S
    PLoS One; 2013; 8(8):e70843. PubMed ID: 23967120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle.
    Chiu HC; Huang WR; Liao TL; Wu HY; Munir M; Shih WL; Liu HJ
    PLoS One; 2016; 11(9):e0162356. PubMed ID: 27603133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of β-catenin Ser60 by polo-like kinase 1 drives the completion of cytokinesis.
    Yu JE; Kim SO; Hwang JA; Hong JT; Hwang J; Soung NK; Cha-Molstad H; Kwon YT; Kim BY; Lee KH
    EMBO Rep; 2021 Dec; 22(12):e51503. PubMed ID: 34585824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plk3 phosphorylates topoisomerase IIalpha at Thr(1342), a site that is not recognized by Plk1.
    Iida M; Matsuda M; Komatani H
    Biochem J; 2008 Apr; 411(1):27-32. PubMed ID: 18062778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Genetic Toggle for Chemical Control of Individual Plk1 Substrates.
    Johnson JM; Hebert AS; Drane QH; Lera RF; Wan J; Weaver BA; Coon JJ; Burkard ME
    Cell Chem Biol; 2020 Mar; 27(3):350-362.e8. PubMed ID: 32017920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calmodulin activation of polo-like kinase 1 is required during mitotic entry.
    Dai G; Qian Y; Chen J; Meng FL; Pan FY; Shen WG; Zhang SZ; Xue B; Li CJ
    Biochem Cell Biol; 2013 Oct; 91(5):287-94. PubMed ID: 24032677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic identification of Hsp70 as a new Plk1 substrate in arsenic trioxide-induced mitotically arrested cells.
    Chen YJ; Lin YP; Chow LP; Lee TC
    Proteomics; 2011 Nov; 11(22):4331-45. PubMed ID: 21887822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear envelope breakdown during prophase.
    Li H; Liu XS; Yang X; Song B; Wang Y; Liu X
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14633-8. PubMed ID: 20679239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TTDN1 is a Plk1-interacting protein involved in maintenance of cell cycle integrity.
    Zhang Y; Tian Y; Chen Q; Chen D; Zhai Z; Shu HB
    Cell Mol Life Sci; 2007 Mar; 64(5):632-40. PubMed ID: 17310276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Osaka thyroid (Cot) phosphorylates Polo-like kinase (PLK1) at Ser137 but not at Thr210.
    Wu B; Jiang P; Mu Y; Wilmouth RC
    Biol Chem; 2009 Dec; 390(12):1271-7. PubMed ID: 19804365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate.
    Nakajima H; Toyoshima-Morimoto F; Taniguchi E; Nishida E
    J Biol Chem; 2003 Jul; 278(28):25277-80. PubMed ID: 12738781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.